Sponsor Check › Person
Related person on Form D filings · address state as listed: CA · listed Mar 2, 2011 → Jun 8, 2026
Data last updated: Oct 23, 2026, 5:45 PM ET · Courts (RECAP) last checked: Oct 23, 2026, 11:56 PM ET · SEC enforcement last checked: not yet
Privacy: business-related public information only. Residential addresses are never shown; only the state from the filing.
The five facts investors ask about first. Each section states what was searched and when. Items still in human review are not shown.
None found in sources searched.
Sources searched: CourtListener bulk data (RECAP dockets as of 2026-09-30) — federal district + bankruptcy courts; live RECAP re-check pending. State courts: not yet searched. PACER: not searched. · Last checked Oct 23, 2026, 11:56 PM ET.
State courts: not yet searched. No state offers a lawful automated statewide source PartnerFacts can use today. Texas (re:SearchTX) terms prohibit storing results in a database open to third parties; New York (WebCivil) and Massachusetts (MassCourts) require a browser check that blocks scripted queries; California has no statewide index (58 county portals; Rule of Court 2.503 grants name-based access case by case); Florida, Utah and Illinois offer paid or partial access whose terms for automated use are unverified. Washington (dw.courts.wa.gov; bulk index reports under a JISC data-dissemination agreement), Delaware (CourtConnect; Court of Chancery not included) and Arizona (apps.azcourts.gov/publicaccess, which has an official channel to request high-volume access) are the candidates; PartnerFacts will request written permission before any automated search. Federal courts are searched through CourtListener / RECAP.
SEC enforcement searched: SEC litigation releases and administrative proceedings — respondent names in the sec.gov index titles (30,205 releases, 1995-09-19 to 2026-10-23); release text is read only to confirm a candidate. Names that appear only in the body of a release are not found. — not yet searched; State securities regulators searched: AZ (Corporation Commission Securities Division), CA (DFPI — 16 of 12,159 DFPI respondent pages read so far; sponsor-name matches are read first), DE (DOJ Investor Protection Unit), TX (State Securities Board), WA (DFI) — last crawled Oct 23, 2026, 9:57 PM ET. Other states: not yet searched.
Not yet searched.
Search queued. Results are added automatically; check back later or follow this page to be notified.
None found in sources searched.
Sources searched: Federal bankruptcy courts via CourtListener / RECAP archive (federal district courts, federal bankruptcy courts). State courts: not yet searched. PACER: not searched (RECAP only). · Last checked Oct 23, 2026, 11:56 PM ET.
State courts: not yet searched. No state offers a lawful automated statewide source PartnerFacts can use today. Texas (re:SearchTX) terms prohibit storing results in a database open to third parties; New York (WebCivil) and Massachusetts (MassCourts) require a browser check that blocks scripted queries; California has no statewide index (58 county portals; Rule of Court 2.503 grants name-based access case by case); Florida, Utah and Illinois offer paid or partial access whose terms for automated use are unverified. Washington (dw.courts.wa.gov; bulk index reports under a JISC data-dissemination agreement), Delaware (CourtConnect; Court of Chancery not included) and Arizona (apps.azcourts.gov/publicaccess, which has an official channel to request high-volume access) are the candidates; PartnerFacts will request written permission before any automated search. Federal courts are searched through CourtListener / RECAP.
Comparisons are made for sponsors and sponsor groups, not individual people.
2 of 25 offerings report sales commissions totalling $5,200,000; 0 report finder's fees; 1 reports proceeds to related persons totalling $2,279,507. (includes amounts the issuer reported as estimates)
| Source | Offering (latest filing) | Sales commissions | Finder's fees | To insiders | Paid to sell it |
|---|---|---|---|---|---|
| EDGAR ↗ | Jun 8, 2026 D File 021-586604 | $0 | $0 | $0 | None listed on this filing |
| EDGAR ↗ | Nov 13, 2025 D File 021-563900 | $0 | $0 | $0 | None listed on this filing |
| EDGAR ↗ | Sep 18, 2024 D File 021-524399 | $0 | $0 | $0 | None listed on this filing |
| EDGAR ↗ | Feb 13, 2024 D File 021-505095 | $0 | $0 | $0 | None listed on this filing |
| EDGAR ↗ | Oct 12, 2023 D/A File 021-464469 | $0 | $0 | $0 | None listed on this filing |
| EDGAR ↗ | Jul 20, 2023 D/A File 021-453315 | $0 (est.) | $0 (est.) | $0 (est.) The Issuer will pay an affiliate of the General Partner a quarterly management fee generally equal to a percentage of the Issuer's capital commitments or invested capital as specified in the Issuer's partnership agreement. | Snowbridge Securities LLC BrokerCheck CRD 301996 ↗ J.P. Morgan Securities LLC BrokerCheck CRD 79 ↗ First Forte Consultancy FZE no CRD number reported |
| EDGAR ↗ | Jul 20, 2023 D/A File 021-453320 | $0 (est.) | $0 (est.) | $0 (est.) The Issuer will pay an affiliate of the General Partner a quarterly management fee generally equal to a percentage of the Issuer's capital commitments or invested capital as specified in the Issuer's partnership agreement. | Snowbridge Securities LLC BrokerCheck CRD 301996 ↗ J.P. Morgan Securities LLC BrokerCheck CRD 79 ↗ First Forte Consultancy FZE no CRD number reported |
| EDGAR ↗ | Nov 5, 2021 D File 021-420132 | $0 | $0 | $0 | None listed on this filing |
| EDGAR ↗ | Jun 17, 2021 D File 021-403392 | $0 | $0 | $0 (est.) An affiliate of the General Partner will receive an annual management fee payable by the Issuer in advance. The management fee will generally be equal to a percentage of commitments or invested capital as specified in the Issuer's partnership agreement. | None listed on this filing |
| EDGAR ↗ | Feb 25, 2021 D File 021-390559 | $0 | $0 | $0 | None listed on this filing |
| EDGAR ↗ | Aug 11, 2020 D File 021-372998 | $0 | $0 | $0 | None listed on this filing |
| EDGAR ↗ | Apr 3, 2020 D File 021-364301 | $0 | $0 | $0 | None listed on this filing |
| EDGAR ↗ | Sep 20, 2019 D File 021-349320 | $0 | $0 | $0 An affiliate of the General Partner will receive an annual management fee payable by the Issuer in advance. The management fee will generally be equal to a percentage of commitments or invested capital as specified in the Issuer's partnership agreement. | None listed on this filing |
| EDGAR ↗ | Mar 20, 2019 D/A File 021-292854 | $0 | $0 | $0 | None listed on this filing |
| EDGAR ↗ | Jan 25, 2019 D File 021-331349 | $0 | $0 | $0 (est.) | None listed on this filing |
| EDGAR ↗ | Jun 12, 2018 D File 021-314375 | $0 | $0 | $0 | None listed on this filing |
| EDGAR ↗ | Mar 21, 2017 D File 021-282968 | $0 | $0 | $0 | None listed on this filing |
| EDGAR ↗ | Jun 23, 2016 D/A File 021-262846 | $0 | $0 | $0 | None listed on this filing |
| EDGAR ↗ | Aug 21, 2015 D File 021-246228 | $0 | $0 | $0 | None listed on this filing |
| EDGAR ↗ | Jul 24, 2015 D File 021-244425 | $0 | $0 | $0 | None listed on this filing |
| EDGAR ↗ | Mar 24, 2015 D File 021-236500 | $0 | $0 | $0 | N/A no CRD number reported |
| EDGAR ↗ | Oct 23, 2012 D/A File 021-165828 | $3,000,000 (est.) | $0 | $0 (est.) | Probitas Funds Group, LLC BrokerCheck CRD 115876 ↗ |
| EDGAR ↗ | Aug 31, 2012 D File 021-183494 | $0 | $0 | $0 (est.) Proceeds will be used for general corporate purposes including, but not limited to, executive salaries. | None listed on this filing |
| EDGAR ↗ | Aug 9, 2011 D File 021-164089 | $2,200,000 (est.) | $0 | $0 (est.) | Probitas Fund Group, LLC BrokerCheck CRD 115876 ↗ |
| EDGAR ↗ | Mar 2, 2011 D File 021-156088 | $0 | $0 | $2,279,507 (est.) This estimate excludes amounts paid and that may be paid to the law firm which two executive officers were/are affiliated. | None listed on this filing |
As reported by the issuer on Form D (Items 12–15), latest filing per offering (one offering = one SEC file number; an amendment updates its offering rather than adding one). "To insiders" = gross proceeds used for payments to executive officers, directors or promoters. "—" = not reported on that filing. Amounts marked (est.) were reported as estimates. "Paid to sell it" = sales compensation recipients named on that filing (Item 12), each linked to FINRA BrokerCheck when a CRD number is reported.
Counted across every filing this person is listed on (latest filing per offering, per issuer).
| Source | Issuer | Role | Filed | Form | Offering | Sold | Investors | Min. investment |
|---|---|---|---|---|---|---|---|---|
| EDGAR ↗ | Infinant Health, Inc. | Director | Jun 8, 2026 | D | $118,230,513 similar: $829,831–$9,999,998 | $39,247,552 | 29 similar: 2–15 | No minimum reported similar: $10,000–$54,310 |
| EDGAR ↗ | Longitude 103.8 East, L.P. group: Longitude Venture | Executive Officer Managing Member of the General Partner | Nov 13, 2025 | D | $100,000,000 similar: $155,000–$5,250,000 | $100,000,000 | 1 similar: 4–27 | No minimum reported similar: $1,000–$100,000 |
| EDGAR ↗ | CuraSen Therapeutics, Inc. | Director | Sep 18, 2024 | D | $45,690,305 similar: $2,000,000–$19,999,994 | $5,785,019 | 7 similar: 2–16 | No minimum reported similar: $10,000–$50,000 |
| EDGAR ↗ | BioAge Labs, Inc. | Director | Feb 13, 2024 | D | $194,390,799 similar: $2,000,000–$19,999,994 | $194,390,799 | 32 similar: 2–16 | $3 similar: $10,000–$50,000 |
| EDGAR ↗ | CuraSen Therapeutics, Inc. | Director | Oct 12, 2023 | D/A | $20,814,709 similar: $2,000,000–$19,999,994 | $17,599,997 | 11 similar: 2–16 | No minimum reported similar: $10,000–$50,000 |
| EDGAR ↗ | Longitude Prime Fund II, L.P. group: Longitude Venture | Executive Officer Managing Member of the General Partner | Jul 20, 2023 | D/A | $200,000,000 similar: $155,000–$5,250,000 | $49,861,875 | 10 similar: 4–27 | No minimum reported similar: $1,000–$100,000 |
| EDGAR ↗ | Longitude Venture Partners V, L.P. group: Longitude Venture | Executive Officer Managing Member of the General Partner | Jul 20, 2023 | D/A | $600,000,000 similar: $155,000–$5,250,000 | $206,679,375 | 18 similar: 4–27 | No minimum reported similar: $1,000–$100,000 |
| EDGAR ↗ | CuraSen Therapeutics, Inc. | Director | Nov 10, 2022 | D | $14,999,997 similar: $2,000,000–$19,999,994 | $14,999,997 | 10 similar: 2–16 | No minimum reported similar: $10,000–$50,000 |
| EDGAR ↗ | Longitude Venture Partners V, L.P. group: Longitude Venture | Executive Officer Managing Member of the General Partner | Jul 21, 2022 | D | $600,000,000 similar: $155,000–$5,250,000 | $0 | 0 similar: 4–27 | No minimum reported similar: $1,000–$100,000 |
| EDGAR ↗ | Longitude Prime Fund II, L.P. group: Longitude Venture | Executive Officer Managing Member of the General Partner | Jul 21, 2022 | D | $200,000,000 similar: $155,000–$5,250,000 | $0 | 0 similar: 4–27 | No minimum reported similar: $1,000–$100,000 |
| EDGAR ↗ | CuraSen Therapeutics, Inc. | Director | Nov 5, 2021 | D | $18,000,000 similar: $2,000,000–$19,999,994 | $18,000,000 | 10 similar: 2–16 | No minimum reported similar: $10,000–$50,000 |
| EDGAR ↗ | Longitude Prime Fund, L.P. group: Longitude Venture | Executive Officer Managing Member of the General Partner | Jun 17, 2021 | D | $130,000,000 similar: $155,000–$5,250,000 | $0 | 0 similar: 4–27 | No minimum reported similar: $1,000–$100,000 |
| EDGAR ↗ | Vera Therapeutics, Inc. | Director | Feb 25, 2021 | D | $70,736,334 similar: $2,000,000–$19,999,994 | $70,736,334 | 23 similar: 2–16 | No minimum reported similar: $10,000–$50,000 |
| EDGAR ↗ | Orbus Therapeutics, Inc. | Director | Aug 11, 2020 | D | $27,000,000 similar: $2,000,000–$19,999,994 | $10,000,000 | 1 similar: 2–16 | No minimum reported similar: $10,000–$50,000 |
| EDGAR ↗ | SutroVax, Inc. | Director | Apr 3, 2020 | D | $110,000,000 similar: $2,000,000–$19,999,994 | $110,000,000 | 23 similar: 2–16 | No minimum reported similar: $10,000–$50,000 |
| EDGAR ↗ | Longitude Venture Partners IV, L.P. group: Longitude Venture | Executive Officer Managing Member of the General Partner | Sep 20, 2019 | D | $550,000,000 similar: $155,000–$5,250,000 | $0 | 0 similar: 4–27 | No minimum reported similar: $1,000–$100,000 |
| EDGAR ↗ | Orbus Therapeutics, Inc. | Director | Mar 20, 2019 | D/A | $39,500,024 similar: $2,000,000–$19,999,994 | $18,500,014 | 16 similar: 2–16 | No minimum reported similar: $10,000–$50,000 |
| EDGAR ↗ | CuraSen Therapeutics, Inc. | Director | Jan 25, 2019 | D | $54,499,989 similar: $2,000,000–$14,000,000 | $27,249,994 | 10 similar: 1–19 | $1 similar: $10,000–$50,000 |
| EDGAR ↗ | SutroVax, Inc. | Director | Jun 12, 2018 | D | $85,682,959 similar: $2,000,000–$19,999,994 | $43,182,959 | 12 similar: 2–16 | No minimum reported similar: $10,000–$50,000 |
| EDGAR ↗ | Orbus Therapeutics, Inc. | Director | Aug 15, 2017 | D | $24,500,012 similar: $2,000,000–$19,999,994 | $12,500,005 | 16 similar: 2–16 | No minimum reported similar: $10,000–$50,000 |
| EDGAR ↗ | SutroVax, Inc. | Director | Mar 21, 2017 | D | $60,150,027 similar: $2,000,000–$19,999,994 | $40,100,007 | 9 similar: 2–16 | No minimum reported similar: $10,000–$50,000 |
| EDGAR ↗ | Longitude Venture Partners III, L.P. group: Longitude Venture | Executive Officer, Director Managing Member of the General Partner of the Issuer | Jun 23, 2016 | D/A | $525,000,000 similar: $155,000–$5,250,000 | $525,000,000 | 70 similar: 4–27 | No minimum reported similar: $1,000–$100,000 |
| EDGAR ↗ | Longitude Venture Partners III, L.P. group: Longitude Venture | Executive Officer, Director Managing Member of the General Partner of the Issuer | Jun 23, 2016 | D/A | $525,000,000 similar: $155,000–$5,250,000 | $525,000,000 | 70 similar: 4–27 | No minimum reported similar: $1,000–$100,000 |
| EDGAR ↗ | Longitude Venture Partners III, L.P. group: Longitude Venture | Executive Officer, Director Managing Member of the General Partner of the Issuer | May 10, 2016 | D | $525,000,000 similar: $155,000–$5,250,000 | $0 | 0 similar: 4–27 | No minimum reported similar: $1,000–$100,000 |
| EDGAR ↗ | Orbus Therapeutics, Inc. | Director | Aug 21, 2015 | D | $32,500,010 similar: $2,000,000–$19,999,994 | $18,000,005 | 15 similar: 2–16 | No minimum reported similar: $10,000–$50,000 |
| EDGAR ↗ | SutroVax, Inc. | Director | Jul 24, 2015 | D | $26,887,178 similar: $2,000,000–$19,999,994 | $12,634,755 | 7 similar: 2–16 | No minimum reported similar: $10,000–$50,000 |
| EDGAR ↗ | Aimmune Therapeutics, Inc. | Director | Mar 24, 2015 | D | $80,000,002 similar: $829,831–$9,999,998 | $80,000,002 | 10 similar: 2–15 | No minimum reported similar: $10,000–$54,310 |
| EDGAR ↗ | Longitude Venture Partners II, L.P. group: Longitude Venture | Executive Officer, Director Managing Member of the General Partner | Oct 23, 2012 | D/A | $385,000,000 | $385,000,000 | 46 | No minimum reported |
| EDGAR ↗ | Longitude Venture Partners II, L.P. group: Longitude Venture | Executive Officer, Director Managing Member of the General Partner | Sep 5, 2012 | D/A | $375,000,000 | $331,562,500 | 24 | No minimum reported |
| EDGAR ↗ | CARDIODX INC | Director | Aug 31, 2012 | D | $58,018,795 | $30,509,397 | 28 | No minimum reported |
| EDGAR ↗ | Longitude Venture Partners II, L.P. group: Longitude Venture | Executive Officer, Director Managing Member of the General Partner | Sep 14, 2011 | D | $375,000,000 | $159,390,863 | 11 | No minimum reported |
| EDGAR ↗ | Longitude Capital Associates II, L.P. group: Longitude Venture | Executive Officer, Director Managing Member of the General Partner | Aug 9, 2011 | D | $375,000,000 | $0 | 0 | $5,000,000 |
| EDGAR ↗ | CARDIODX INC | Director | Mar 2, 2011 | D | $78,325,737 | $57,491,448 | 17 | No minimum reported |
Every row is a Form D or D/A on which the issuer listed this name as a related person. Related-person names are matched on first + last name and the address state on the filing; records that share a name but could not be tied together by a second identifier are listed separately below.
"Similar" = offerings in the same industry claiming the same exemption, filed in the last 5 years: Other Health Care / 506(b) (4,189 filings); Pooled Investment Fund / 506(b) (83,801 filings); Biotechnology / 506(b) (3,253 filings); Biotechnology / 506(c) (163 filings); ranges are the middle half (25th–75th percentile). Computed by PartnerFacts from SEC EDGAR Form D data as of Oct 23, 2026, 5:45 PM ET. Rows without a range: fewer than 30 comparable filings, or not a Rule 506 offering. No ranking or score.
Separate person records under the same name, not combined with this page. Each line says whether it is listed on an issuer this record is also listed on (a second identifier); where it is not, it could be the same person or a different one.
People and management entities the issuers listed as related persons on the same Form D filings as Patrick Enright. Source: the EDGAR rows in the table above. Showing the 40 with the most shared filings.
None found in sources searched.
Sources searched: SEC Regulation A Data Sets (Forms 1-A, 1-K, 1-Z; 2015 Q2 → 2026 Q3); SEC Crowdfunding Offerings Data Sets (Form C family; 2016 Q2 → 2026 Q3); EDGAR form index for 2026 Q3 → 2026 Q4 · Last checked Oct 23, 2026, 8:41 PM ET.
Export this report as PDF (members · included free during the launch period)
No corrections have been requested for this page.
Free. Logged with status: received → under review → fixed / confirmed with source.
If this is you or your firm, add a sourced explanation next to any fact. Reviewed before publishing.
Members get an email when Patrick Enright appears on a new Form D, or when a court case or SEC action is matched to them. See plans →